1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation.
- Publisher:
- Wiley
- Publication Type:
- Journal Article
- Citation:
- Chemical Biology and Drug Design, 2022, 99, (2), pp. 301-307
- Issue Date:
- 2022
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Chem Biol Drug Des - 2021 - Sharma - 1H‐1 2 3‐triazole embedded Isatin‐Benzaldehyde‐bis heteronuclearhydrazones design .pdf | 821.61 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Sharma, B | |
dc.contributor.author | Kumar, S | |
dc.contributor.author | Preeti, | |
dc.contributor.author | Johansen, MD | |
dc.contributor.author | Kremer, L | |
dc.contributor.author | Kumar, V | |
dc.date.accessioned | 2022-12-14T01:49:09Z | |
dc.date.available | 2021-10-30 | |
dc.date.available | 2022-12-14T01:49:09Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Chemical Biology and Drug Design, 2022, 99, (2), pp. 301-307 | |
dc.identifier.issn | 1747-0277 | |
dc.identifier.issn | 1747-0285 | |
dc.identifier.uri | http://hdl.handle.net/10453/164387 | |
dc.description.abstract | Rapid growth of global drug-resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin-derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H-1,2,3-triazole tethered isatin-benzaldehydes improved the antimycobacterial activity on tuberculosis mc<sup>2</sup> 6230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine-2-carbohydrazide produced the opposite effects. The compounds with isoniazid and polar-donating groups at the C-5 position of isatin emerged as the most promising conjugates with MIC<sub>99</sub> = 0.36 µg/ml. The most active compounds were non-cytotoxic to Vero cells (IC<sub>50</sub> >100 µg/ml) with selectivity indices >277. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Chemical Biology and Drug Design | |
dc.relation.isbasedon | 10.1111/cbdd.13984 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 0601 Biochemistry and Cell Biology | |
dc.subject.classification | Biophysics | |
dc.subject.classification | Medicinal & Biomolecular Chemistry | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Antitubercular Agents | |
dc.subject.mesh | Benzaldehydes | |
dc.subject.mesh | Chlorocebus aethiops | |
dc.subject.mesh | Drug Design | |
dc.subject.mesh | Hydrazones | |
dc.subject.mesh | Isatin | |
dc.subject.mesh | Microbial Sensitivity Tests | |
dc.subject.mesh | Mycobacterium tuberculosis | |
dc.subject.mesh | Structure-Activity Relationship | |
dc.subject.mesh | Triazoles | |
dc.subject.mesh | Vero Cells | |
dc.subject.mesh | Vero Cells | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Mycobacterium tuberculosis | |
dc.subject.mesh | Benzaldehydes | |
dc.subject.mesh | Hydrazones | |
dc.subject.mesh | Triazoles | |
dc.subject.mesh | Isatin | |
dc.subject.mesh | Antitubercular Agents | |
dc.subject.mesh | Microbial Sensitivity Tests | |
dc.subject.mesh | Structure-Activity Relationship | |
dc.subject.mesh | Drug Design | |
dc.subject.mesh | Chlorocebus aethiops | |
dc.title | 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation. | |
dc.type | Journal Article | |
utslib.citation.volume | 99 | |
utslib.location.activity | England | |
utslib.for | 0601 Biochemistry and Cell Biology | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Science/School of Life Sciences | |
pubs.organisational-group | /University of Technology Sydney/Strength - CFI - Centre for Inflammation | |
utslib.copyright.status | closed_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-12-14T01:49:08Z | |
pubs.issue | 2 | |
pubs.publication-status | Published | |
pubs.volume | 99 | |
utslib.citation.issue | 2 |
Abstract:
Rapid growth of global drug-resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin-derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H-1,2,3-triazole tethered isatin-benzaldehydes improved the antimycobacterial activity on tuberculosis mc2 6230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine-2-carbohydrazide produced the opposite effects. The compounds with isoniazid and polar-donating groups at the C-5 position of isatin emerged as the most promising conjugates with MIC99 = 0.36 µg/ml. The most active compounds were non-cytotoxic to Vero cells (IC50 >100 µg/ml) with selectivity indices >277.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph